Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download
Asset icon - trade crypto, stocks, and gold on Pluang

Buy & Sell BioNano Genomics Inc (BNGO) – BioNano Genomics Inc Price Today

24H
1W
1M
3M
YTD
1Y
5Y

Aura AI Summary

BNGO trades at $1.15, down 3.36% on the day, with a bullish technical signal from moving averages. The company shows improving financial trends with reduced losses in 2025 (-$26M net income vs. -$112M in 2024) and consistent earnings beats in recent quarters. Recent leadership transition and strong publication growth in optical genome mapping applications highlight ongoing business development. Valuation ratios appear attractive with P/S of 0.22 and P/B of 0.29.
The outlook remains speculative given persistent losses but shows operational improvement. Investment opportunity lies in the company's niche genomic technology gaining scientific validation, while risks include cash burn sustainability and competitive pressures in the genomics space. Analyst consensus leans bullish with 57% buy ratings, though profitability remains the key hurdle for sustained stock appreciation.
Read full analysis

Key Stats

  • Market Cap
    $12.76M
  • Sector
    Health
  • 3M Drawdown
    -22.6%
  • Enterprise Value
    $401.80K
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    40 days
$1.15
52W Low: $1.09
12 Feb 2026
52W High: $4.92
10 Sep 2025

BioNano Genomics Inc (BNGO) is currently valued at a market capitalization of $12.76M, with an enterprise value of $401.80K. Over the past 52 weeks, BioNano Genomics Inc has traded between a low of $1.09 and a high of $4.92, highlighting its annual price range. Over the past three months, BioNano Genomics Inc has recorded a drawdown of -22.6%, reflecting recent price volatility. On average, investors hold BioNano Genomics Inc for approximately 40 days, indicating typical investor behavior on the platform.

About BioNano Genomics Inc

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.


Technical Indicators
|
|
|
Overall Summary
Bearish (16)Neutral (3)Bullish (6)

People also bought


US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

Key Stats

  • Market Cap
    $12.76M
  • Sector
    Health
  • 3M Drawdown
    -22.6%
  • Enterprise Value
    $401.80K
  • Dividend Yield
    -
  • Trading Activity
    100% Buy | 0% Sell
  • Typical Hold Time
    40 days
$1.15
52W Low: $1.09
12 Feb 2026
52W High: $4.92
10 Sep 2025

BioNano Genomics Inc (BNGO) is currently valued at a market capitalization of $12.76M, with an enterprise value of $401.80K. Over the past 52 weeks, BioNano Genomics Inc has traded between a low of $1.09 and a high of $4.92, highlighting its annual price range. Over the past three months, BioNano Genomics Inc has recorded a drawdown of -22.6%, reflecting recent price volatility. On average, investors hold BioNano Genomics Inc for approximately 40 days, indicating typical investor behavior on the platform.

Let’s invest in this asset by signing up or download!